BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22328565)

  • 1. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment.
    Mathieu S; Pereira B; Dubost JJ; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2012 Jun; 51(6):1107-11. PubMed ID: 22328565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
    Mathieu S; Pereira B; Couderc M; Rabois E; Dubost JJ; Soubrier M
    Rheumatology (Oxford); 2013 Jan; 52(1):204-9. PubMed ID: 23065359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
    Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
    Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab.
    Raterman HG; Levels H; Voskuyl AE; Lems WF; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2013 Apr; 72(4):560-5. PubMed ID: 22589377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR; Engstrand S; Berglin E; Johnson O
    Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab).
    Cypiene A; Laucevicius A; Venalis A; Ryliskyte L; Dadoniene J; Petrulioniene Z; Kovaite M; Laskova V; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():119-22. PubMed ID: 18605247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis.
    Galarraga B; Khan F; Kumar P; Pullar T; Belch JJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1418-23. PubMed ID: 19734293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-α therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up.
    Capkin E; Karkucak M; Kiris A; Durmus I; Karaman K; Karaca A; Tosun M; Ayar A
    Rheumatology (Oxford); 2012 May; 51(5):910-4. PubMed ID: 22253025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M; Nurmohamed MT; Wolbink G; Voskuyl AE; de Koning M; van de Stadt R; Twisk JW; Dijkmans BA; Lems WF
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
    Provan SA; Berg IJ; Hammer HB; Mathiessen A; Kvien TK; Semb AG
    PLoS One; 2015; 10(6):e0130709. PubMed ID: 26114946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies.
    Angel K; Provan SA; Hammer HB; Mowinckel P; Kvien TK; Atar D
    Fundam Clin Pharmacol; 2011 Aug; 25(4):511-7. PubMed ID: 20825487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
    Steiner G; Urowitz MB
    Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients.
    Georgiadis AN; Voulgari PV; Argyropoulou MI; Alamanos Y; Elisaf M; Tselepis AD; Drosos AA
    Semin Arthritis Rheum; 2008 Aug; 38(1):13-9. PubMed ID: 18191989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation.
    Booth AD; Wallace S; McEniery CM; Yasmin ; Brown J; Jayne DR; Wilkinson IB
    Arthritis Rheum; 2004 Feb; 50(2):581-8. PubMed ID: 14872502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
    Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF
    Ann Rheum Dis; 2011 Sep; 70(9):1575-80. PubMed ID: 21571731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study.
    Linde A; Gerdts E; Fevang BT; Eilertsen RK; Kringeland E; Alsing CL; Midtbø H
    Blood Press; 2024 May; 33(1):2353167. PubMed ID: 38824646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.